Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249559 · ClinicalTrials.gov registry record
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 4
- Enrollment target
NCT02249559: Clinical Trial study, sponsored by NYU Langone Health.
NCT02249559 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02249559 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the safety and efficacy of unilateral gamma knife subthalamotomy for Parkinson's disease in patients deemed poor candidates for deep brain stimulation.
Primary Outcome
* Safety of GK subthalamotomy in the management of PD as measured by stable findings on neurologic exam at each clinic visit (hemiballismus, dyskinesias, sensory changes) and the absence of Serious Adverse Events (SAE) attributable to treatment. * Because this study does not have a control group, we will compare the non-inferiority of GK subthalamotomy to published outcomes in PD patients undergoing other forms of management.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-09 |
Why NCT02249559 stopped before completion
NCT02249559 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02249559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02249559 about?
NCT02249559 is a clinical study titled "Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease". This is a pilot study to evaluate the safety and efficacy of unilateral gamma knife subthalamotomy for Parkinson's disease in patients deemed poor candidates for deep brain stimulation.
What is the current status of trial NCT02249559?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2014-07. Estimated completion is 2017-09.
Who is sponsoring clinical trial NCT02249559?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia